Anson Funds Management LP Oncolytics Biotech Inc Transaction History

Anson Funds Management LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2023 Feb 14, 2024	SELL	$1.22 - $2.09 $1.82 Million - $3.11 Million	-1,487,737 Reduced 28.06%	3,814,299 $5.15 Million
Q3 2023 Nov 13, 2023	BUY	$1.98 - $3.24 $10.5 Million - $17.2 Million	5,302,036 New	5,302,036 $11.6 Million

1.21M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $49.2M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

Stay updated on Anson Funds Management LP with notifications on news.